Introduction
============

Gallstones are the most frequent cause of acute pancreatitis (AP) worldwide \[[@goz037-B1]\] and up to 8% of those with symptomatic cholelithiasis will have AP. Although most patients with acute biliary pancreatitis (ABP) have mild disease, 20% have severe disease and up to 5% of patients die of ABP \[[@goz037-B2]\]. The first-line treatment of ABP is cholecystectomy and the timing of surgery depends on the severity of the ABP. Current guidelines recommend cholecystectomy during the index admission for patients with mild ABP (MABP) \[[@goz037-B3]\] and evidence supports the safety of early cholecystectomy in these patients \[[@goz037-B4]\].

Multiple studies have reported a lack of adherence to these guidelines \[[@goz037-B5], [@goz037-B6]\]. In the USA, the degree of adherence has not been reported in recent years and the impact of cholecystectomy on 30-day readmission rates remains unclear. In this study, we aimed to assess national trends in cholecystectomy completion rates during index admissions for MABP and to identify predictors of 30-day readmission and cholecystectomy in this cohort.

Materials and methods
=====================

Study design and data source
----------------------------

We conducted a retrospective longitudinal study of admissions to US acute-care hospitals for AP. Data on hospital admissions of all adult patients (age ≥18 years) between 2010 and 2014 were extracted from the National Readmissions Database (NRD). NRD is an inpatient database with several key features---it 'provides sufficient data for analysis across hospital types and the study of readmissions for relatively uncommon disorders and procedures, \[contains\] discharge data from 27 geographically dispersed states, accounting for 57.8% of the total US resident population and 56.6% of all US hospitalizations, is designed to support national readmission analyses, and cannot be used for regional, state-, or hospital-specific analyses'. This database tracks patient readmission to same or any other hospital in the USA for every calendar year (1 January through 31 December) but does not link patient data across the preceding or subsequent years. We therefore excluded index admissions that occurred in December from our analysis because readmissions for those cases could not be tracked. The dataset provides de-identified information regarding each admission, including demographics, comorbidities, discharge diagnoses, procedures performed, outcomes, and costs of stay. These databases exclude observation admissions, rehabilitation hospitals, and chemical-dependency units. This study was exempted from IRB review, as no identifiable patient data were included in the database.

Study population
----------------

We used *International Classification of Diseases, Ninth Revision, Clinical Modification* (ICD-9-CM) codes to identify all hospitalized adults (age ≥18 years) with a primary diagnosis of AP (ICD-9-CM code 577.0), a secondary diagnosis of cholelithiasis or choledocholithiasis, and survived to hospital discharge. All diagnostic and procedural codes used for classifications are shown in [Supplementary Table 1](#sup1){ref-type="supplementary-material"}. AP-related admissions were identified by querying for all diagnostic ICD-9-CM codes corresponding to AP. We excluded patients with acute kidney injury, intensive-care-unit admission, hypotension, shock, and acute hypoxic respiratory failure.

###### 

Baseline characteristics of patients with mild acute biliary pancreatitis after being stratified by readmission and cholecystectomy status

  Variable                                                            Overall (*n* = 255,695)   Stratified by readmission   Stratified by cholecystectomy                                                      
  ------------------------------------------------------------------- ------------------------- --------------------------- ------------------------------- ---------------- ---------------- ---------------- ---------
  Sex, *n* (%)                                                                                                                                              \<0.001                                            \<0.001
    Male                                                              105,530 (41.3)            90,831 (40.7)               14,699 (45.5)                                    64,698 (45.0)    40,832 (36.5)    
    Female                                                            150,165 (58.7)            132,538 (59.3)              17,627 (54.5)                                    79,037 (55.0)    71,128 (63.5)    
  Age, *n* (%)                                                                                                                                              \<0.001                                            
    18--44 years                                                      74,750 (29.2)             66,200 (29.6)               8,550 (26.4)                                     35,889 (25.0)    38,861 (34.7)    
    45--64 years                                                      94,358 (36.9)             81,955 (36.7)               12,403 (38.4)                                    55,115 (38.3)    39,243 (35.0)    
    65--84 years                                                      69,713 (27.3)             60,803 (27.2)               8,910 (27.6)                                     40,319 (28.1)    29,394 (26.3)    
    \>84 years                                                        16,874 (6.6)              14,411 (6.5)                2,463 (7.6)                                      12,412 (8.6)     4,462 (4.0)      
  Weekend admission, *n* (%)                                                                                                                                0.10                                               \<0.001
    No                                                                188,097 (73.6)            164,105 (73.5)              23,992 (74.2)                                    106,739 (74.3)   81,358 (72.7)    
    Yes                                                               67,598 (26.4)             59,264 (26.5)               8,334 (25.8)                                     36,996 (25.7)    30,602 (27.3)    
  Hospital size, *n* (%)                                                                                                                                    \<0.001                                            \<0.001
    Small                                                             35,747 (14.0)             31,287 (14.0)               4,460 (13.8)                                     22,157 (15.4)    13,590 (12.1)    
    Medium                                                            65,624 (25.7)             58,061 (26.0)               7,563 (23.4)                                     36,646 (25.5)    28,978 (25.9)    
    Large                                                             154,324 (60.4)            134,021 (60.0)              20,303 (62.8)                                    84,932 (59.1)    69,392 (62.0)    
  Hospital type, *n* (%)                                                                                                                                    0.11                                               0.14
    Government                                                        34,794 (13.6)             30,164 (13.5)               4,630 (14.3)                    20,021 (13.9)    14,773 (13.2)                     
    Private, not-for-profit                                           182,781 (71.5)            159,895 (71.6)              22,886 (70.8)                   102,568 (71.4)   80,213 (71.6)                     
    Private, profit                                                   38,120 (14.9)             33,310 (14.9)               4,810 (14.9)                    21,146 (14.7)    16,974 (15.2)                     
  Hospital location and teaching status, *n* (%)                                                                                                            \<0.001                                            \<0.001
    Metropolitan non-teaching                                         103,015 (40.3)            90,553 (40.5)               12,462 (38.5)                                    55,417 (38.6)    47,598 (42.5)    
    Metropolitan teaching                                             121,074 (47.3)            105,094 (47.0)              15,980 (49.4)                                    68,471 (47.6)    52,603 (47.0)    
    Nonmetropolitan hospital                                          31,606 (12.4)             27,722 (12.4)               3,884 (12.0)                                     19,847 (13.8)    11,759 (10.5)    
  Median household income, percentile based on postal code, *n* (%)   0.005                                                                                 0.005                                              
    0--25th percentile                                                74,842 (29.8)             64,870 (29.5)               9,972 (31.3)                                     42,737 (30.2)    32,105 (29.1)    
    26--50th percentile                                               64,436 (25.6)             56,526 (25.7)               7,910 (24.8)                                     36,199 (25.6)    28,237 (25.6)    
    51--75th percentile                                               60,397 (24.0)             52,736 (24.0)               7,661 (24.0)                                     33,181 (23.5)    27,216 (24.7)    
    76--100th percentile                                              51,863 (20.6)             45,537 (20.7)               6,326 (19.9)                                     29,209 (20.7)    22,654 (20.6)    
  Payer, *n* (%)                                                                                                                                            \<0.001                                            \<0.001
    Medicare                                                          95,143 (37.2)             81,334 (36.4)               13,809 (42.7)                                    59,331 (41.3)    35,812 (32.1)    
    Medicaid                                                          36,795 (14.4)             31,243 (14.0)               5,552 (17.2)                                     20,562 (14.3)    16,233 (14.5)    
    Private insurance                                                 86,157 (33.7)             77,312 (34.6)               8,845 (27.3)                                     43,623 (30.3)    42,534 (38.0)    
    Self-pay/other                                                    36,913 (14.4)             32,893 (14.7)               4,020 (12.4)                                     19,840 (13.8)    17,073 (15.2)    
  Disposition, *n* (%)                                                                                                                                      \<0.001                                            \<0.001
    Routine                                                           223,401 (87.4)            197,756 (88.5)              25,645 (79.3)                                    120,821 (84.0)   102,580 (91.6)   
    Short-term hospital                                               2,755 (1.1)               2,146 (1.0)                 609 (1.9)                                        2,479 (1.7)      276 (0.2)        
    Skilled nursing facility                                          11,387 (4.5)              9,357 (4.2)                 2,030 (6.3)                                      7,681 (5.3)      3,706 (3.3)      
    Home health care                                                  14,429 (5.6)              11,343 (5.1)                3,086 (9.5)                                      9,234 (6.4)      5,195 (4.6)      
    Against medical advice                                            3,722 (1.5)               2,766 (1.2)                 956 (3.0)                                        3,518 (2.4)      204 (0.2)        
  Comorbidity, *n* (%)                                                                                                                                                                                         
    Myocardial infarction                                             9,522 (3.7)               7,925 (3.5)                 1,597 (4.9)                     \<0.001          6,333 (4.4)      3,189 (2.8)      \<0.001
    Congestive heart failure                                          14,148 (5.5)              11,391 (5.1)                2,757 (8.5)                     \<0.001          9,615 (6.7)      4,533 (4.0)      \<0.001
    Peripheral vascular disease                                       9,317 (3.6)               7,718 (3.5)                 1,599 (4.9)                     \<0.001          6,296 (4.4)      3,021 (2.7)      \<0.001
    Cerebrovascular disease                                           4,178 (1.6)               3,513 (1.6)                 665 (2.1)                       \<0.001          2,801 (1.9)      1,377 (1.2)      \<0.001
    Dementia                                                          2,759 (1.1)               2,310 (1.0)                 449 (1.4)                       0.002            2,022 (1.4)      737 (0.7)        \<0.001
    COPD                                                              35,143 (13.7)             29,554 (13.2)               5,589 (17.3)                    \<0.001          21,857 (15.2)    13,286 (11.9)    \<0.001
    Rheumatoid disease                                                4,965 (1.9)               4,045 (1.8)                 920 (2.8)                       \<0.001          3,102 (2.2)      1,863 (1.7)      \<0.001
    Peptic ulcer disease                                              4,000 (1.6)               3,295 (1.5)                 705 (2.2)                       \<0.001          2,780 (1.9)      1,220 (1.1)      \<0.001
    Mild liver disease                                                30,748 (12.0)             26,366 (11.8)               4,382 (13.6)                    \<0.001          20,384 (14.2)    10,364 (9.3)     \<0.001
    Diabetes mellitus                                                 48,833 (19.1)             41,808 (18.7)               7,025 (21.7)                    \<0.001          30,258 (21.1)    18,575 (16.6)    \<0.001
    Diabetes mellitus plus complications                              5,433 (2.1)               4,317 (1.9)                 1,116 (3.5)                     \<0.001          3,504 (2.4)      1,929 (1.7)      \<0.001
    Hemiplegia or paraplegia                                          993 (0.4)                 821 (0.4)                   172 (0.5)                       \<0.001          535 (0.4)        458 (0.4)        0.405
    Renal disease                                                     16,129 (6.3)              12,831 (5.7)                3,298 (10.2)                    \<0.001          11,013 (7.7)     5,116 (4.6)      \<0.001
    Cancer                                                            4,787 (1.9)               3,715 (1.7)                 1,072 (3.3)                     \<0.001          3,414 (2.4)      1,373 (1.2)      \<0.001
    Moderate or severe liver disease                                  3,802 (1.5)               2,821 (1.3)                 981 (3.0)                       \<0.001          3,338 (2.3)      464 (0.4)        \<.0001
    Metastatic cancer                                                 2,083 (0.8)               1,458 (0.7)                 625 (1.9)                       \<0.001          1,725 (1.2)      358 (0.3)        \<0.001
    AIDS                                                              607 (0.2)                 443 (0.2)                   164 (0.5)                       \<0.001          451 (0.3)        156 (0.1)        \<0.001
  Charlson Comorbidity Index, *n* (%)                                 \<0.001                                                                               \<0.001                                            
    0                                                                 129,241 (50.5)            116,428 (52.1)              12,813 (39.6)                                    63,391 (44.1)    65,850 (58.8)    
    1                                                                 67,938 (26.6)             59,307 (26.6)               8,631 (26.7)                                     40,395 (28.1)    27,543 (24.6)    
    \>1                                                               58,515 (22.9)             47,633 (21.3)               10,882 (33.7)                                    39,948 (27.8)    18,567 (16.6)    
  Secondary diagnoses, *n* (%)                                                                                                                                                                                 
    Cholangitis                                                       6,703 (2.6)               5,765 (2.6)                 938 (2.9)                       0.06             4,281 (3.0)      2,423 (2.2)      \<0.001
    Bile-duct obstruction                                             49,819 (19.5)             40,760 (18.2)               9,059 (28)                      \<0.001          42,301 (29.4)    7,518 (6.7)      \<0.001
    Alcohol abuse                                                     29,549 (11.6)             24,342 (10.9)               5,207 (16.1)                    \<0.001          24,545 (17.1)    5,004 (4.5)      \<0.001
    Smoking                                                           67,960 (26.6)             58,011 (26)                 9,949 (30.7)                    \<0.001          42,029 (29.2)    25,931 (23.2)    \<0.001
    Chronic pancreatitis                                              16,435 (6.4)              12,093 (5.4)                4,342 (13.4)                    \<0.001          14,674 (10.2)    1,761 (1.6)      \<0.001
  Procedure or surgery, *n* (%)                                                                                                                                                                                
    ERCP                                                              63,857 (25.0)             56,112 (25.1)               7,745 (23.9)                    0.02             34,759 (24.2)    29,098 (26.0)    \<0.001
    Percutaneous biliary tube placement                               1,367 (0.5)               946 (0.4)                   421 (1.3)                       \<0.001          1,047 (0.7)      320 (0.3)        \<0.001

COPD, chronic obstructive pulmonary disease; AIDS, acquired immuno-deficiency syndrome; ERCP, endoscopic retrograde cholangiopancreatography.

Definitions of variables, comorbidities, and other covariates
-------------------------------------------------------------

The NRD collects demographic information, including age, sex, income, and primary and secondary insurance for all admitted patients. It also contains hospital information (e.g. bed size, location, and teaching status). The Charlson Comorbidity Index (CCI) was calculated and used for comorbidity assessment. To limit our data capture only to patients with MABP (as defined by the revised Atlanta criteria \[[@goz037-B7]\]), we restricted our analyses to AP cases that were not associated with organ failure; thus, we evaluated only those cases that did not have acute kidney injury, hypoxia, acute respiratory failure, shock, or death during the index hospitalization. These surrogates were chosen to circumvent the lack of ICD-9 codes for pancreatitis severity in the database. We have provided the definition of hospital size in [Supplementary Table 2](#sup1){ref-type="supplementary-material"}.

###### 

Most common reasons for readmission of patients with acute mild biliary pancreatitis during the index hospitalization

  Reason for readmission                             Percentage (*n* = 32,326)
  -------------------------------------------------- ---------------------------
  Acute pancreatitis                                 31.00
  Calculus of gallbladder with cholecystitis         3.26
  Calculus of gallbladder with acute cholecystitis   3.17
  Chronic pancreatitis                               2.96
  Sepsis                                             2.55
  Cyst and pseudocyst of pancreas                    2.54
  Calculus of gallbladder without cholecystitis      1.90
  Post-operative infection                           1.27
  Calculus of bile duct without cholecystitis        1.18
  Pancreatic cancer                                  1.09
  Pneumonia                                          0.88

Outcomes
========

The primary outcomes of this study were to assess the trend in rates of cholecystectomy and endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy in patients admitted with MABP to US hospitals. We performed a multivariate regression analysis to (i) identify predictors of index cholecystectomy in patients with MABP and (ii) identify predictors of all-cause 30-day readmission in these patients.

Statistical analysis
====================

The statistical analysis described below was published previously \[[@goz037-B8]\] and is reused here under Creative Commons license. Data are presented as mean ± standard deviation (SD) for continuous variables or weighted frequency (%) for categorical variables. A univariate analysis was performed to assess differences between the two groups (no cholecystectomy during index admission vs performance of the procedure during index admission); continuous variables were compared by using *t*-tests and categorical variables were compared by using χ^2^ tests. In addition, multivariable analysis was used to assess differences between the groups in terms of the outcomes of interest while adjusting for patient and hospital characteristics. Survey logistic-regression analysis was used to model 30-day readmission risk and cholecystectomy. We used the Cochran-Armitage test to assess trends in cholecystectomy. The NRD is based on a complex sampling design that includes stratification, clustering, and weighting; SAS Survey procedures facilitate the unbiased assessment of population estimates. *P*-values \<0.001 were considered statistically significant because of the large sample size; this significance criterion has been used by previous National Inpatient Sample studies. All analyses were performed with SAS (version 9.4; SAS Institute Inc., Cary, NC).

Results
=======

Baseline patient characteristics
--------------------------------

We identified 255,695 index MABP discharges during the study period. Baseline characteristics of these patients, stratified by readmission and cholecystectomy status, are listed in [Table 1](#goz037-T1){ref-type="table"}. Of the 255,695 patients identified with an index admission of MABP, 32,326 (12.6%) were readmitted within 30 days. [Figure 1A and B](#goz037-F1){ref-type="fig"} shows decreasing trends in cholecystectomy and ERCP with sphincterotomy during this period (*P* \< 0.001). Overall, 45.4% of patients underwent cholecystectomy and 20.6% underwent ERCP with sphincterotomy in 2010; in 2014, 42.0% and 18.6% underwent cholecystectomy and ERCP with sphincterotomy, respectively. [Figure 1C](#goz037-F1){ref-type="fig"} shows differences in cholecystectomy rates for patients who did vs did not undergo ERCP with sphincterotomy. [Figure 1D](#goz037-F1){ref-type="fig"} shows differences in 30-day readmission rates for patients who did vs did not undergo cholecystectomy during the index admission. [Table 2](#goz037-T2){ref-type="table"} lists the most common reasons for readmission in patients with index admissions of MABP.

![Outcomes of patients with mild acute biliary pancreatitis (MABP), 2010--2014. (A) Trends of cholecystectomy. (B) Trends of endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy in MABP. (C) Rates of cholecystectomy, stratified by ERCP with sphincterotomy status. (D) 30-day readmission rate, stratified by cholecystectomy status.](goz037f1){#goz037-F1}

Factors associated with readmission and cholecystectomy
-------------------------------------------------------

We performed multivariate logistic-regression analysis to identify predictors of 30-day all-cause readmission and factors associated with cholecystectomy during the index admission for patients admitted with MABP ([Table 3](#goz037-T3){ref-type="table"}): The odds of all-cause readmission and cholecystectomy decreased with patient age. Patients admitted to a large hospital \[odds ratio (OR), 1.11; 95% confidence interval (CI), 1.03--1.19\] were more likely to be readmitted within 30 days. Those admitted to medium (OR, 1.25; 95% CI, 1.15--1.36) or large hospitals (OR, 1.31; 95% CI, 1.21--1.41) were more likely to undergo cholecystectomy than those admitted to a small hospital.Compared with patients who had a routine discharge home, patients who were discharged to a short-term hospital (OR, 1.68; 95% CI, 1.4--2.01), to a skilled nursing facility (OR, 1.14; 95% CI, 1.02--1.28), with home health care (OR, 1.51; 95% CI, 1.38--1.65), or against medical advice (OR, 1.79; 95% CI, 1.55--2.07) had significantly higher odds of readmission. Patients who underwent ERCP with sphincterotomy or cholecystectomy on index admission had decreased odds of readmission (OR, 0.78; 95% CI, 0.74--0.84 and OR, 0.37; 95% CI, 0.35--0.39, respectively). Patients with higher CCI or alcohol abuse were less likely to undergo cholecystectomy.

###### 

Predictors of 30-day readmission and cholecystectomy for patients admitted with mild acute biliary pancreatitis

  Variable                                                     Comparator vs reference                              30-day readmission     Cholecystectomy                               
  ------------------------------------------------------------ ---------------------------------------------------- ---------------------- ---------------------- ---------------------- ---------
  Sex                                                          Female vs male                                       0.938 (0.896--0.982)   0.006                  1.156 (1.116--1.197)   \<0.001
  Age group, years                                             45--64 vs 18--44                                     0.930 (0.876--0.987)   0.02                   0.771 (0.741--0.802)   \<.001
  65--84 vs 18--44                                             0.698 (0.640--0.761)                                 \<0.001                0.881 (0.831--0.934)   \<0.001                
  \>84 vs 18--44                                               0.642 (0.572--0.719)                                 \<0.001                0.410 (0.377--0.446)   \<0.001                
  Payer                                                        Medicaid vs Medicare                                 0.967 (0.886--1.054)   0.44                   1.144 (1.076--1.217)   \<0.001
  Private insurance vs Medicare                                0.722 (0.668--0.781)                                 \<0.001                1.356 (1.285--1.431)   \<0.001                
  Self-pay/another vs Medicare                                 0.699 (0.635--0.769)                                 \<0.001                1.333 (1.248--1.424)   \<0.001                
  Median household income as percentile based on postal code   26th--50th vs 0--25th percentile                     0.951 (0.889--1.017)   0.14                   0.994 (0.946--1.045)   0.83
  51th--75th vs 0--25th percentile                             1.037 (0.974--1.103)                                 0.26                   0.997 (0.946--1.052)   0.92                   
  76th--100th vs 0--25th percentile                            1.003 (0.935--1.076)                                 0.94                   0.916 (0.860--0.976)   0.007                  
  Weekend admission                                            Yes vs no                                            0.994 (0.947--1.043)   0.81                   1.104 (1.069--1.142)   \<0.001
  Hospital size                                                Medium vs small                                      0.950 (0.876--1.031)   0.22                   1.250 (1.149--1.359)   \<0.001
  Large vs small                                               1.106 (1.029--1.189)                                 0.006                  1.305 (1.210--1.408)   \<0.001                
  Hospital type                                                Private, not-for-profit vs government                0.944 (0.883--1.010)   0.10                   1.066 (0.988--1.150)   0.10
  Private, for-profit vs government                            0.992 (0.911--1.081)                                 0.85                   1.077 (0.986--1.177)   0.10                   
  Teaching status of hospital                                  Metropolitan teaching vs metropolitan non-teaching   0.944 (0.896--0.994)   0.03                   1.137 (1.070--1.208)   \<0.001
  Nonmetropolitan hospital vs metropolitan non-teaching        0.884 (0.811--0.963)                                 0.005                  0.788 (0.722--0.861)   \<0.001                
  Length of stay, days                                         [\>]{.ul}7 vs \<7                                    1.791 (1.703--1.883)   \<0.001                1.578 (1.514--1.645)   \<0.001
  Disposition                                                  Short-term hospital vs routine                       1.680 (1.404--2.011)   \<0.001                --                     --
  Skilled nursing facility vs routine                          1.140 (1.020--1.275)                                 0.02                   --                     --                     
  Home health care vs routine                                  1.511 (1.383--1.652)                                 \<0.001                --                     --                     
  Against medical advice vs routine                            1.789 (1.548--2.069)                                 \<0.001                --                     --                     
  Charlson Comorbidity Index                                   1 vs 0                                               1.150 (1.086--1.218)   \<0.001                0.753 (0.727--0.780)   \<0.001
  \>1 vs 0                                                     1.575 (1.482--1.674)                                 \<0.001                0.532 (0.509--0.555)   \<0.001                
  Alcohol abuse                                                Yes vs no                                            1.150 (1.086--1.218)   \<0.001                0.222 (0.210--0.236)   \<0.001
  ERCP with sphincterotomy                                     Yes vs no                                            0.783 (0.735--0.835)   \<0.001                1.007 (0.962--1.054)   0.76
  Cholecystectomy                                              Yes vs no                                            0.371 (0.352--0.391)   \<0.001                --                     --

CI, confidence interval; ERCP, endoscopic retrograde cholangiopancreatography.

Discussion
==========

Cholecystectomy is recommended following an MABP episode to prevent the development of biliary-related complications based on a PONCHO trial that was very well done \[[@goz037-B9]\]. The PONCHO trial was a multicenter study performed in 23 hospitals in the Netherlands that randomly assigned 266 inpatients to interval cholecystectomy or same-admission cholecystectomy. The primary endpoint of this study was recurrent gallstone-related complications within 6 months. This study found that that interval group had 17% gallstone-related complications compared to 5% in the same-admission group. We also observed that those who underwent cholecystectomy during the index admission were less likely to be readmitted than patients who did not. This difference is a cause for concern from a health-care-use standpoint. Although our findings are original in terms of their pertaining to the US health-care system, analogous observations have been made in other countries \[[@goz037-B10]\].

Our study used multivariate regression analyses to show that multiple factors affected the odds of cholecystectomy during the index admission. In terms of demographic factors, cholecystectomies were mainly undertaken in younger patients, especially those aged 18--44 years. This higher rate may be attributable to the younger group's perceived better medical fitness for surgery. Women were more likely to undergo cholecystectomy during the same admission for MABP and were subsequently less likely to be readmitted for any cause. The higher rate of surgery for women may be associated with surgeon preference, with previous research showing less complicated surgery in women \[[@goz037-B11]\]. In terms of hospitalization factors, weekend admissions were associated with higher rates of cholecystectomy and subsequently lower rates of readmission. Previous research has shown similar rates of surgical complications after weekend and weekday cholecystectomies \[[@goz037-B12]\]. Although there has been a slight decrease in the rate of cholecystectomy and ERCP over the course of this study, we did not see an increase in readmission for unclear reason.

Our study confirms that index cholecystectomy is the single most effective intervention for decreasing the odds of all-cause and MABP-specific readmissions. We have previously shown that, when patients are stratified by the cause of pancreatitis, only those with gallstone pancreatitis accrued a statistically significant decrease in readmission rates after the index admission \[[@goz037-B13]\]. We have also observed that undergoing ERCP with sphincterotomy is associated with a modest decrease in the readmission rate. These findings are congruent with previous research that showed a mitigating but not terminating effect of sphincterotomy on the recurrence of gallstone pancreatitis \[[@goz037-B14]\].

The reasons for delayed cholecystectomy, even when it is clearly indicated, are multifaceted. First, there is a pervasive belief among physicians regarding the danger of the procedure shortly after recovery from an AP episode. This notion has been challenged by research reporting no difference in technical complexity between early and delayed cholecystectomy, even when cholecystitis is the indication for the operation, which theoretically has more surgical complications in the setting of an acutely inflamed gallbladder \[[@goz037-B15]\]. Second, economic restraints and a changing reimbursement landscape may prompt emphasis on shorter hospitalizations. Third, although guidelines and recommendations may appear ideal from a patient-outcome perspective, their implementation may not be practical or realistic in all settings such as safety-net hospitals or other facilities with limited resources \[[@goz037-B16]\].

One potential solution is the implementation of a medical discharge−surgical readmission pathway, which would plan for elective outpatient cholecystectomy within 2 weeks after discharge from an MABP admission. In this paradigm, medical and anesthesia pre-operative assessment, as well as informed consent for the surgery, are finalized before discharge \[[@goz037-B17]\]. Another option entails direct admission to a surgical service, which was previously reported to increase the rate of index cholecystectomy and decrease the risk of readmission \[[@goz037-B18]\].

Although our study offers substantial strength from the large sample size and allows identification of robust associations, we nonetheless acknowledge numerous inherent and unavoidable limitations. First, we conducted a retrospective, uncontrolled study that did not allow inference of causality and at best was an exploratory examination of associations. Second, ICD-9 coding almost certainly includes inaccuracies, which are common with any administrative database. Third, the scope of our examination is limited by critical absences in clinical data, such as anthropomorphic characteristics (e.g. body mass index) and laboratory values (e.g. C-reactive protein). Lastly, the limited period of data collection (before publication of the pivotal PONCHO study in 2015) may not portray changes in practice that hopefully are influenced by the dissemination of findings from that well-designed trial. Another limitation of our study is that some of the readmissions could have been related to bile-ductal leaks or pancreatic necrosis, which we are unable to tell with confidence because of the known difficulty in looking at large administrative databases retrospectively.

Although the trends observed in our current analysis suggest considerable deviation from accepted guidelines, the practice may change according to that high-level evidence and the publication of new guidelines.

Conclusions
===========

For patients with MABP, cholecystectomy during the index admission was the strongest predictive factor associated with a decreased risk of readmission. However, the proportion of patients undergoing these procedures steadily decreased from 2010 to 2014. This decrease could not be explained by increasing disease severity or comorbidity. Our research emphasizes the need for policies to encourage providers to perform cholecystectomy during the index admission, as highlighted by high-quality evidence in the literature.
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